Jamjoom Pharma to disclose Q2 2024 financials on Aug. 6

18/07/2024 Argaam
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Jamjoom Pharmaceuticals Factory Co. plans to disclose Q2 2024 financial statements before the opening of the trading session on the Saudi Exchange (Tadawul) on Aug. 6, 2024, according to a statement to Tadawul.

 

The company will organize a conference call on the same day at 3:00 pm (KSA Timing) after the session close to discuss the investors’ inquiries as regards Q2 financials.

 
 
Jamjoom is expected to report a net income of SAR 106.61 million in Q2 2024, according to the analyst forecasts compiled with Argaam.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.